Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Shendelman Shoshana, Président et CEO. Officer active across 2 companies, notably Applied Therapeutics Inc.. In total, 14 reports have been published. Split: 4 buys · 5 sells. Total volume traded: €2.2m. History available since 13 September 2021. The latest transaction was filed on 5 August 2024 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shendelman Shoshana
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
701 shares@ US$14.68992.1% of flowCommon StockSEC:0001209191-21-055932:0
Canonical exit: 12 Dec 2021 (T+90)
14 of 14 declarations
About Shendelman Shoshana
Shendelman Shoshana is President and CEO at Applied Therapeutics Inc. and Applied Therapeutics, Inc. She has filed 14 disclosures in total, and, across the recent filings sample held, the prevailing transaction type is selling, with purchases of EUR 104267 and sales of EUR 2130175 between 2021-09-14 and 2024-08-14.